Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis.
about
X-ray crystallography-promoted drug design of carbonic anhydrase inhibitorsCrystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio choleraeA class of carbonic anhydrase I - selective activators.Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus.Identification of metal dithiocarbamates as a novel class of antileishmanial agentsAntitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolates.Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.Antiglaucoma carbonic anhydrase inhibitors: a patent review.Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors.Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.Acetazolamide for the treatment of idiopathic intracranial hypertension.Bacterial, fungal and protozoan carbonic anhydrases as drug targets.How many carbonic anhydrase inhibition mechanisms exist?Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases.Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates.β-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis.Interplay between a cytosolic and a cell surface carbonic anhydrase in pH homeostasis and acid tolerance of Leishmania.Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase.Cloning, expression and biochemical characterization of a β-carbonic anhydrase from the soil bacterium Enterobacter sp. B13.Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis.7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits α-carbonic anhydrases without hydrolysis of the lactam ring.Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.Anion inhibition studies of a beta carbonic anhydrase from the malaria mosquito Anopheles gambiae.Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases.A Key Opinion Leader interview: insight into the research and career of Prof. Claudiu T Supuran.Dipotassium-trioxohydroxytetrafluorotriborate, K₂[B₃O₃F₄OH], is a potent inhibitor of human carbonic anhydrases.Synthesis of 3,4-dihydroxypyrrolidine-2,5-dione and 3,5-dihydroxybenzoic acid derivatives and evaluation of the carbonic anhydrase I and II inhibition.Crystallography and Its Impact on Carbonic Anhydrase Research
P2860
Q27700041-79175823-2710-4602-BFF6-23FA0B490849Q27702913-39141CA7-2BE8-494B-BD42-8A3B3C6FA55FQ31140231-75B098C9-91F7-4E26-B746-CC932BDA5B8AQ33798397-CE78CEDC-7F0E-4E8A-8026-F367E439D00AQ35168873-C8E82EB5-DBAF-4EC2-8E39-8403F67BE42EQ36171517-191940C6-E904-4F83-B330-403B324579CFQ38102745-3697445C-1F02-4346-AD4F-B15C865DCCFFQ38102786-4B854750-4EE0-4541-8DF5-7D1EC71D922DQ38221060-96B54D1B-F1E1-438E-873B-0D76E1040EDBQ38263008-AC575234-3D39-474F-ADD1-E35C5EDA6F7EQ38266496-F1D1580A-0053-4E64-A502-87D23E6A55B8Q38543994-3566C6B6-EA56-4BBF-B99F-1EDBCD6B1EE4Q38559435-CC206515-A36A-4092-82A5-53457EAD234CQ38653464-99214C5E-626E-4A44-B778-E55F7FE562D4Q38733892-54D3D6A8-47CA-4E6F-8158-325B35EBC9DEQ38742510-957E2870-F62F-4E76-A477-C9FD8CE97F26Q39782661-6AD3A48C-17D3-4AAB-8F2B-7AC8F66044D6Q40110123-551C22FD-895F-49FB-8F26-3EC86481BF0EQ40166814-E19F2059-51A5-4400-AA04-261DBBC2A629Q40381739-C0B85893-1B91-4675-8FC0-AB0CC28BD1B2Q41491551-54709A3B-4B80-497C-82F2-6B8DDADC23F7Q46279624-936E9BA6-6BBF-49DD-B8BD-7F5C3C89B46AQ46544659-DDBC0E5B-AB29-4572-9092-2482B9DAA7B5Q46774097-A56ACE7D-44C6-449E-BADF-D2E5FBBCB49AQ47756079-34CEAFFC-884B-4639-A013-75BAE70AF63EQ48021639-0BD4E59A-BB40-4764-86F7-F5D038EF4452Q48110370-68C35E3A-B38C-4C03-A972-AFD1AD9DCA87Q48334768-E08C83D6-D69C-4E0E-8468-D06CAD782822Q48710407-F3EF4154-E4ED-4BBF-B2B4-CCC03373B26EQ53298711-1998A48D-240A-4AF3-A3A9-AC3D4D45342EQ57300400-79F0182F-F03C-4235-8660-F4923696303A
P2860
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Dithiocarbamates strongly inhi ...... om Mycobacterium tuberculosis.
@en
Dithiocarbamates strongly inhi ...... om Mycobacterium tuberculosis.
@nl
type
label
Dithiocarbamates strongly inhi ...... om Mycobacterium tuberculosis.
@en
Dithiocarbamates strongly inhi ...... om Mycobacterium tuberculosis.
@nl
prefLabel
Dithiocarbamates strongly inhi ...... om Mycobacterium tuberculosis.
@en
Dithiocarbamates strongly inhi ...... om Mycobacterium tuberculosis.
@nl
P2093
P2860
P1476
Dithiocarbamates strongly inhi ...... om Mycobacterium tuberculosis.
@en
P2093
Alfonso Maresca
Claudiu T Supuran
Daniela Vullo
Fabrizio Carta
P2860
P304
P356
10.3109/14756366.2011.641015
P577
2011-12-06T00:00:00Z